Diabetes Induces Cardiac Fibroblast Activation, Promoting a Matrix‐Preserving Nonmyofibroblast Phenotype, Without Stimulating Pericyte to Fibroblast Conversion
Journal of the American Heart Association · 2023
DOI: 10.1161/jaha.122.027463 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2023. Verfasst von Linda Alex und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Wilf Family Cardiovascular Research Institute Department of Medicine (Cardiology), Albert Einstein College of Medicine Bronx NY. Hauptthemen laut MEDLINE: Pericytes, Diabetes Mellitus. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Interstitial and perivascular fibrosis may contribute to diabetes‐associated heart failure. Pericytes can convert to fibroblasts under conditions of stress and have been implicated in the pathogenesis of fibrotic diseases. We hypothesized that in diabetic hearts, pericytes may convert to fibroblasts, contributing to fibrosis and to the development of diastolic dysfunction. Methods and Results Using pericyte:fibroblast dual reporter (NG2 Dsred [neuron‐glial antigen 2 red fluorescent protein variant]; PDGFRα EGFP [platelet‐derived growth factor receptor alpha enhanced green fluorescent protein]) mice in a type 2 diabetic db/db background, we found that diabetes does not significantly affect pericyte density but reduces the myocardial pericyte:fibroblast ratio. Lineage tracing using the inducible NG2 CreER driver, along with reliable labeling of fibroblasts with the PDGFRα reporter system, showed no significant pericyte to fibroblast conversion in lean and db/db hearts. In addition, db/db mouse cardiac fibroblasts did not undergo myofibroblast conversion and had no significant induction of structural collagens but exhibited a matrix‐preserving phenotype, associated with increased expression of antiproteases, matricellular genes, matrix cross‐linking enzymes, and the fibrogenic transcription factor cMyc . In contrast, db/db mouse cardiac pericytes had increased expression of Timp3 , without any changes in expression of other fibrosis‐associated genes. The matrix‐preserving phenotype of diabetic fibroblasts was associated with induction of genes encoding oxidative ( Ptgs2 /cycloxygenase‐2, and Fmo2 ) and antioxidant proteins ( Hmox1 , Sod1 ). In vitro, high glucose partially recapitulated the in vivo changes in diabetic fibroblasts.
Conclusions
Diabetic fibrosis is not mediated through pericyte to fibroblast conversion but involves acquisition of a matrix‐preserving fibroblast program, which is independent of myofibroblast conversion and is only partially explained by the effects of the hyperglycemic environment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Wilf Family Cardiovascular Research Institute Department of Medicine (Cardiology), Albert Einstein College of Medicine Bronx NY.
ORCID-Profile: Linda Alex, Izabela Tuleta, Anis Hanna, Nikolaos G Frangogiannis
Förderung
- NHLBI NIH HHS
Zitieren
APA
Alex, L., Tuleta, I., Hanna, A., & Frangogiannis, N. G. (2023). Diabetes Induces Cardiac Fibroblast Activation, Promoting a Matrix‐Preserving Nonmyofibroblast Phenotype, Without Stimulating Pericyte to Fibroblast Conversion. Journal of the American Heart Association. https://doi.org/10.1161/jaha.122.027463
Vancouver
Alex L, Tuleta I, Hanna A, Frangogiannis NG. Diabetes Induces Cardiac Fibroblast Activation, Promoting a Matrix‐Preserving Nonmyofibroblast Phenotype, Without Stimulating Pericyte to Fibroblast Conversion. Journal of the American Heart Association. 2023. doi:10.1161/jaha.122.027463
BibTeX
@article{Alex2023,
author = {Alex, Linda and Tuleta, Izabela and Hanna, Anis and Frangogiannis, Nikolaos G},
title = {Diabetes Induces Cardiac Fibroblast Activation, Promoting a Matrix‐Preserving Nonmyofibroblast Phenotype, Without Stimulating Pericyte to Fibroblast Conversion},
journal = {Journal of the American Heart Association},
year = {2023},
doi = {10.1161/jaha.122.027463}
}
EUVIMED